Assignee
NANJING SHIJIANG MEDICINE TECH CO LTD
CN·0 granted patents·8 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
8 records- 0139US2024350478A1Application of benzisoquinoline diketone compound in treatment of tumorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0239US2025120946A1Use of pyrrole compound in treatment of tumorsNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0338US2024350460A1Application of hydrazide compound in tumor treatmentNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0438US2025000826A1Application of benzanilide compound in tumor treatmentNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0538US2025268923A1Application of tetracycline compound in treatment of tumorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0635US2024124445A1Benzene ring compound and use thereofNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 0734US2023355647A1Marker for determining anti-cancer effects of mitochondrial oxidative phosphorylation pathway inhibitorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 0832US2023098254A1Scutellariae radix compounds and use thereof for inhibiting oxidative phosphorylation pathway of mitochondriaNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANJING SHIJIANG MEDICINE TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →